The Global Glioblastoma Market is expected to register a CAGR of 7.40% during the forecast period with a market value of USD 1,643.4 Million till 2025. Glioblastoma is a malignant grade IV tumour. The increasing incidence rates, the rise in product approvals, and growing research in the field are projected to drive the growth of the global glioblastoma market. On the other hand, the...